SirenCare Secures $9.5M Funding to Revolutionize Chronic Disease Management

SirenCare, a pioneering company dedicated to transforming healthcare for chronic disease and aging populations, is excited to announce that it has successfully raised $9.5 million in its latest funding round. This significant investment underscores the growing confidence in SirenCare’s innovative approach to improving patient outcomes and experiences. By engaging with both healthcare providers and payers, SirenCare is at the forefront of augmenting traditional healthcare with tech-enabled clinical models designed to deliver whole person care. Central to this mission is the Siren Diabetic Foot Program, which leverages our proprietary Siren Socks—an advanced solution that continuously monitors foot temperature to facilitate the early detection of diabetic foot ulcers, a common and potentially severe complication for individuals with diabetes. The funding will be strategically allocated to enhance our technological infrastructure, expand our clinical programs, and deepen our partnerships within the healthcare ecosystem. By doing so, we aim to scale our impact, reaching more patients in need of preventive care and significantly reducing the risk of serious complications associated with chronic conditions. As we embark on this exciting phase of growth, we remain committed to our mission of delivering actionable insights and comprehensive care solutions that not only advance clinical practice but also empower individuals to take control of their health outcomes. Thank you to all our investors and partners for believing in our vision to reshape the landscape of chronic disease management. Together, we can drive meaningful changes in healthcare and improve the quality of life for countless individuals battling chronic conditions.